Phosphate homeostasis pathways

Phosphate homeostasis pathways are the interconnected physiological, cellular, and molecular systems responsible for maintaining stable inorganic phosphate concentrations in the body[1][2][5]. These pathways involve the intestines, kidneys, bones, and soft tissue, coordinated by key regulators such as the hormone fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), and vitamin D metabolites (notably, 1,25-dihydroxyvitamin D)[1][2][5]. The main points of control are sodium/phosphate (Na+/Pi) co-transporters in the intestines and kidneys (e.g., SLC34A1/SLC34A3 for the kidney, SLC34A2 for intestinal absorption), the FGF23 receptor complex (requiring αKlotho as cofactor), and feedback regulation involving bone resorption and renal excretion[1][2][3]. Disorders of these pathways result in clinically significant disease, including hypophosphatemia, hyperphosphatemia, and diseases of bone and mineral metabolism such as chronic kidney disease-mineral bone disorder (CKD-MBD), rickets, and osteomalacia[2][5]. Because "Phosphate homeostasis pathways" refer broadly to regulatory mechanisms rather than a specific molecular entity, it is not a valid molecular target for drug discovery without specifying one of the molecular components (such as FGF23, NaPi-IIa/SLC34A1, or αKlotho)[2][3]. The term may be misapplied when used as a target for pharmacological intervention.

Other names

Phosphate regulation pathwaysPhosphate balance mechanismsPhosphate regulatory network